| Product Code: ETC13063566 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The panic disorder market in India is experiencing growth due to increasing awareness about mental health issues and the availability of effective treatments. The market includes a range of pharmaceuticals such as selective serotonin reuptake inhibitors (SSRIs), benzodiazepines, and cognitive behavioral therapy (CBT) options. The key players in the market are investing in research and development to introduce new and improved medications for panic disorder. The rising prevalence of stress and anxiety among the Indian population, coupled with better access to healthcare services, is driving the market forward. Additionally, government initiatives to address mental health issues and reduce stigma are expected to further boost market growth in the coming years. Overall, the India panic disorder market presents opportunities for pharmaceutical companies and mental health practitioners to cater to the growing demand for effective treatments.
The India panic disorder market is witnessing several key trends, with an increasing awareness about mental health issues driving demand for effective treatments. There is a growing preference for non-pharmacological interventions such as cognitive behavioral therapy (CBT) and relaxation techniques over traditional medication, as patients seek more holistic approaches to managing their symptoms. Telemedicine and online therapy platforms are also gaining popularity, providing convenient access to mental health professionals for those unable to visit traditional healthcare facilities. Additionally, there is a rising interest in lifestyle modifications, including exercise and mindfulness practices, as complementary strategies to alleviate panic disorder symptoms. Overall, the market is evolving towards a more patient-centric and comprehensive approach to managing panic disorder in India.
In the India panic disorder market, some key challenges include limited awareness and understanding of mental health issues among the general population, leading to underreporting and misdiagnosis of panic disorder. Additionally, there is a shortage of mental health professionals and treatment facilities, especially in rural areas, resulting in limited access to appropriate care for individuals with panic disorder. Stigma surrounding mental health issues also poses a significant barrier to seeking help and receiving adequate treatment. Furthermore, the high cost of mental health services and medications can be prohibitive for many individuals, further hindering their ability to manage their panic disorder effectively. Addressing these challenges will require concerted efforts to increase awareness, improve access to mental health services, reduce stigma, and make treatment more affordable and accessible for all individuals in India.
The panic disorder market in India presents significant investment opportunities in the pharmaceutical sector for companies specializing in the development and commercialization of innovative treatments for mental health disorders. With a growing awareness and acceptance of mental health issues in India, there is a rising demand for effective medications and therapies to manage panic disorder. Investing in research and development of novel drug formulations, digital health solutions, and personalized treatment approaches tailored to the unique needs of Indian patients could yield substantial returns. Additionally, partnerships with local healthcare providers and government initiatives aimed at improving mental health services can further enhance market penetration and revenue potential in the Indian panic disorder market.
In India, the government has introduced several policies to address mental health issues, including panic disorder. The Mental Healthcare Act of 2017 aims to provide mental healthcare services and protect the rights of individuals with mental illness, including panic disorder. The National Mental Health Programme (NMHP) works towards integrating mental health services into primary healthcare and promoting community-based mental health care. Additionally, the government has launched the District Mental Health Programme (DMHP) to provide mental health services at the district level. These initiatives focus on increasing awareness, reducing stigma, and improving access to mental health services for individuals with panic disorder and other mental health conditions in India.
The future outlook for the panic disorder market in India appears promising, driven by the increasing awareness about mental health issues, growing acceptance of seeking professional help, and advancements in treatment options. The market is expected to witness significant growth with the rising prevalence of panic disorder cases in the country, coupled with efforts to reduce the stigma associated with mental health conditions. Additionally, the government`s initiatives to promote mental well-being and the expanding healthcare infrastructure are likely to further propel the market growth. As a result, there is a growing demand for effective therapies, including medication and therapy, creating opportunities for pharmaceutical companies and mental health professionals to cater to the needs of individuals suffering from panic disorder in India.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Panic Disorder Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Panic Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 India Panic Disorder Market - Industry Life Cycle |
3.4 India Panic Disorder Market - Porter's Five Forces |
3.5 India Panic Disorder Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 India Panic Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 India Panic Disorder Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.8 India Panic Disorder Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 India Panic Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health issues in India |
4.2.2 Growing acceptance of seeking professional help for mental health disorders |
4.2.3 Rising prevalence of panic disorders in India |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health disorders leading to underreporting |
4.3.2 Limited access to mental health services in rural areas of India |
5 India Panic Disorder Market Trends |
6 India Panic Disorder Market, By Types |
6.1 India Panic Disorder Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 India Panic Disorder Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 India Panic Disorder Market Revenues & Volume, By Medication, 2021 - 2031F |
6.1.4 India Panic Disorder Market Revenues & Volume, By Psychotherapy, 2021 - 2031F |
6.1.5 India Panic Disorder Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.2 India Panic Disorder Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 India Panic Disorder Market Revenues & Volume, By SSRIs & SNRIs, 2021 - 2031F |
6.2.3 India Panic Disorder Market Revenues & Volume, By Exposure Therapy, 2021 - 2031F |
6.2.4 India Panic Disorder Market Revenues & Volume, By Medication + Therapy, 2021 - 2031F |
6.3 India Panic Disorder Market, By Therapy Type |
6.3.1 Overview and Analysis |
6.3.2 India Panic Disorder Market Revenues & Volume, By Pharmacological, 2021 - 2031F |
6.3.3 India Panic Disorder Market Revenues & Volume, By Non-Pharmacological, 2021 - 2031F |
6.3.4 India Panic Disorder Market Revenues & Volume, By Multimodal, 2021 - 2031F |
6.4 India Panic Disorder Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 India Panic Disorder Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Panic Disorder Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 India Panic Disorder Market Revenues & Volume, By Mental Health Centers, 2021 - 2031F |
7 India Panic Disorder Market Import-Export Trade Statistics |
7.1 India Panic Disorder Market Export to Major Countries |
7.2 India Panic Disorder Market Imports from Major Countries |
8 India Panic Disorder Market Key Performance Indicators |
8.1 Number of mental health awareness campaigns conducted |
8.2 Percentage increase in individuals seeking treatment for panic disorders |
8.3 Availability of mental health professionals per capita in urban and rural areas |
9 India Panic Disorder Market - Opportunity Assessment |
9.1 India Panic Disorder Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 India Panic Disorder Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 India Panic Disorder Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.4 India Panic Disorder Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 India Panic Disorder Market - Competitive Landscape |
10.1 India Panic Disorder Market Revenue Share, By Companies, 2024 |
10.2 India Panic Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |